Pan-cancer landscape of epigenetic factor expression predicts tumor outcome

被引:9
作者
Cheng, Michael W. [1 ]
Mitra, Mithun [2 ,3 ]
Coller, Hilary A. [1 ,2 ,3 ,4 ]
机构
[1] Univ Calif Los Angeles, Bioinformat Interdept Program, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA
关键词
DNA METHYLATION; CHROMATIN; EPIGENOME; ENVIRONMENT; MECHANISMS; REGULATORS; HALLMARKS; PATTERNS; GENETICS; THERAPY;
D O I
10.1038/s42003-023-05459-w
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Oncogenic pathways that drive cancer progression reflect both genetic changes and epigenetic regulation. Here we stratified primary tumors from each of 24 TCGA adult cancer types based on the gene expression patterns of epigenetic factors (epifactors). The tumors for five cancer types (ACC, KIRC, LGG, LIHC, and LUAD) separated into two robust clusters that were better than grade or epithelial-to-mesenchymal transition in predicting clinical outcomes. The majority of epifactors that drove the clustering were also individually prognostic. A pan-cancer machine learning model deploying epifactor expression data for these five cancer types successfully separated the patients into poor and better outcome groups. Single-cell analysis of adult and pediatric tumors revealed that expression patterns associated with poor or worse outcomes were present in individual cells within tumors. Our study provides an epigenetic map of cancer types and lays a foundation for discovering pan-cancer targetable epifactors. A pan-cancer machine learning model using epifactor expression data for five cancer types and single-cell analysis of adult and pediatric tumors reveal expression patterns associated with poor or worse outcomes are present in individual cells within tumors.
引用
收藏
页数:18
相关论文
共 80 条
[1]   Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target [J].
Abdelfattah, Nourhan ;
Kumar, Parveen ;
Wang, Caiyi ;
Leu, Jia-Shiun ;
Flynn, William F. ;
Gao, Ruli ;
Baskin, David S. ;
Pichumani, Kumar ;
Ijare, Omkar B. ;
Wood, Stephanie L. ;
Powell, Suzanne Z. ;
Haviland, David L. ;
Kerrigan, Brittany C. Parker ;
Lang, Frederick F. ;
Prabhu, Sujit S. ;
Huntoon, Kristin M. ;
Jiang, Wen ;
Kim, Betty Y. S. ;
George, Joshy ;
Yun, Kyuson .
NATURE COMMUNICATIONS, 2022, 13 (01)
[2]   Echoes of the embryo: using the developmental biology toolkit to study cancer [J].
Aiello, Nicole M. ;
Stanger, Ben Z. .
DISEASE MODELS & MECHANISMS, 2016, 9 (02) :105-114
[3]   The molecular hallmarks of epigenetic control [J].
Allis, C. David ;
Jenuwein, Thomas .
NATURE REVIEWS GENETICS, 2016, 17 (08) :487-500
[4]   Systematic pan-cancer analysis of tumour purity [J].
Aran, Dvir ;
Sirota, Marina ;
Butte, Atul J. .
NATURE COMMUNICATIONS, 2015, 6
[5]   Gene Ontology: tool for the unification of biology [J].
Ashburner, M ;
Ball, CA ;
Blake, JA ;
Botstein, D ;
Butler, H ;
Cherry, JM ;
Davis, AP ;
Dolinski, K ;
Dwight, SS ;
Eppig, JT ;
Harris, MA ;
Hill, DP ;
Issel-Tarver, L ;
Kasarskis, A ;
Lewis, S ;
Matese, JC ;
Richardson, JE ;
Ringwald, M ;
Rubin, GM ;
Sherlock, G .
NATURE GENETICS, 2000, 25 (01) :25-29
[6]   Epigenetic Determinants of Cancer [J].
Baylin, Stephen B. ;
Jones, Peter A. .
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2016, 8 (09)
[7]   CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING [J].
BENJAMINI, Y ;
HOCHBERG, Y .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) :289-300
[8]  
Blighe K., 2020, PCATOOLS EVERYTHING, DOI 10.18129/B9.bioc.PCAtools
[9]   Dynamic EMT: a multi-tool for tumor progression [J].
Brabletz, Simone ;
Schuhwerk, Harald ;
Brabletz, Thomas ;
Stemmler, Marc P. .
EMBO JOURNAL, 2021, 40 (18)
[10]   clValid: An R package for cluster validation [J].
Brock, Guy ;
Datta, Susmita ;
Pihur, Vasyl ;
Datta, Somnath .
JOURNAL OF STATISTICAL SOFTWARE, 2008, 25 (04) :1-22